SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-364952
Filing Date
2021-12-22
Accepted
2021-12-22 16:05:56
Documents
12
Period of Report
2021-12-16
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d252751d8k.htm   iXBRL 8-K 25316
  Complete submission text file 0001193125-21-364952.txt   147474

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA epzm-20211216.xsd EX-101.SCH 2890
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20211216_lab.xml EX-101.LAB 18140
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20211216_pre.xml EX-101.PRE 11407
6 EXTRACTED XBRL INSTANCE DOCUMENT d252751d8k_htm.xml XML 3342
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 211513280
SIC: 2834 Pharmaceutical Preparations